A detailed history of Charter Research & Investment Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Charter Research & Investment Group, Inc. holds 14,086 shares of PFE stock, worth $363,841. This represents 0.3% of its overall portfolio holdings.

Number of Shares
14,086
Previous 15,661 10.06%
Holding current value
$363,841
Previous $438,000 7.08%
% of portfolio
0.3%
Previous 0.35%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $43,627 - $49,439
-1,575 Reduced 10.06%
14,086 $407,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $47,404 - $54,435
-1,831 Reduced 10.47%
15,661 $434,000
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $41,572 - $50,749
-950 Reduced 5.15%
17,492 $765,000
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $232 - $275
-5 Reduced 0.03%
18,442 $967,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $14,274 - $17,687
-312 Reduced 1.66%
18,447 $955,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $413 - $612
10 Added 0.05%
18,759 $1.11 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $17,662 - $22,689
450 Added 2.46%
18,749 $806,000
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $10,369 - $11,768
315 Added 1.75%
18,299 $717,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $18,356 - $23,803
565 Added 3.24%
17,984 $646,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $6,471 - $7,266
-175 Reduced 0.99%
17,419 $755,000
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $24,000 - $26,368
-640 Reduced 3.51%
17,594 $747,000
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $23,415 - $24,963
-710 Reduced 3.75%
18,234 $662,000
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $630,077 - $668,533
18,944
18,944 $686,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Charter Research & Investment Group, Inc. Portfolio

Follow Charter Research & Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Research & Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Charter Research & Investment Group, Inc. with notifications on news.